February 29, 2020Open Access

Features and outcome of AIH patients without elevation of IgG

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

BACKGROUND these patients are indistinguishable from other patients with AIH with respect to biochemical markers, liver histology, disease severity and treatment response, but might represent a subgroup with a higher chance of remission after drug withdrawal.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Hartl et al. (Sat,) studied this question.

synapsesocial.com/papers/6a004d2eb124fe581985d346 https://doi.org/https://doi.org/10.1016/j.jhepr.2020.100094

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis2017 · 134 citations
2Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis2014 · 106 citations
3Long-term management and prognosis of autoimmune hepatitis (AIH): A single center experience2001 · 143 citations
4A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis2016 · 111 citations
5Autoimmune hepatitis in Denmark: Incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study2013 · 355 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo